Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chinese Mindray Sees Increased International Growth Through U.S. Datascope Acquisition

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Shenzhen-based Mindray Medical International saw strong international growth through its acquisition of American Datascope's patient monitoring business in May, the company said in a second quarter earnings call Sept. 4

You may also be interested in...



China’s Mindray Refutes Merit Of Report That Sent Stock Plummeting

Mindray stock recovers from freefall after allegations that China’s leading medical device company overstated its earnings and engaged in fraudulent accounting practices.

A Closer Look: China’s Mindray Buys Zonare Of U.S. With Home Market In Mind

China’s largest medical device company is buying its way to a highly exclusive club of global high-end ultrasound manufacturers. While management expects synergy by marrying American technology with Chinese manufacturing, some see a fragmented strategy trying to offer all things for all people.

China’s Mindray Rushes To Meet Demand Surge for Patient Monitors Following May Earthquake

BEIJING - With a spike in orders for patient monitors following China's 7.9 magnitude earthquake, Mindray Medical International has ramped up production to supply hospitals throughout the devastated region

Related Content

UsernamePublicRestriction

Register

OM014079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel